Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Once Upon A Time

The Lung Cancer Initiative of NC will host its annual Evening of Hope Gala, Once Upon A Time , on Saturday, April 27, at North Ridge Country Club in Raleigh, North Carolina. last year's gala raised $132,500 to help support lung cancer research in North Carolina. The Lung Cancer Initiative of North...

Ready, Set, CRUSH!

Colorectal cancer is the fourth most common cancer diagnosed in men and in women and the second leading cause of cancer death in the U.S. says the American Cancer Society. One in 22 men and one in 24 women will be diagnosed with colorectal cancer in their lifetime. The Duke Cancer Institute...

Blood Tests Predict Effectiveness of Hormonal Therapies

A multi-institutional group of clinical researchers, led by the Duke Cancer Institute’s Andrew Armstrong, MD, McS, FACP, published a new report this month in the Journal of Clinical Oncology , that describes results from the PROPHECY study, which prospectively compared two blood tests to assess how...

Vaccine for HER2 Breast Cancer Shows Early Promise

A vaccine developed by Duke Cancer Institute researchers has shown early promise in targeting the HER2 protein that fuels a deadly form of breast cancer. In a phase 1 clinical trial that enrolled 22 women with recurrent cancers that overexpress the HER2 protein, the vaccine demonstrated an ability...

Metastatic Cancer Survivor Dismisses Fear; Embraces “Eye Of The Tiger”

Join us at facebook.com/dukecancerinstitute on Wednesday, May 1, at noon for a live panel discussion featuring cancer survivor and cycling enthusiast Tom Vibert, his oncologist John Strickler and Katie Sweet, senior manager of communications with The V Foundation for Cancer Research. Our own...

'Angels Among Us' Funds Research, Celebrates Hope

Every spring, come rain or come shine, patients, survivors, caregivers, loved ones, and Duke faculty and staff gather at the Angels Among Us 5K and Walk of Hope to celebrate hope and raise funds to fight brain cancer. In its 25-year history, the event has raised nearly $25 million for the cause...

Hanks Receives ASCI Young Physician-Scientist Award

Duke Cancer Institute medical oncologist Brent Hanks, MD, PhD , has been recognized with an ASCI 2019 Young Physician-Scientist Award by the American Society for Clinical Investigation. Hanks is one of 35 “outstanding physician-scientists” being recognized by ASCI nationally and one of two at Duke...

C3O Drills Down On The Canine-To-Human Biomedical Pipeline

While there have been many successes with newer chemotherapies, targeted therapies, and immunotherapies, many cancer types in the human population don’t respond well to therapy. Of those disease types that do, the short-term and long-term toxicities to the body can be quite significant. There’s a...

Antonia Appointed Director Of DCI Center For Cancer Immunotherapy

Scott Antonia, MD, PhD, who joined Duke on Monday, Feb. 25, has been appointed director of the newly formed DCI Center for Cancer Immunotherapy, a DCI Strategic Plan priority that aims to enhance the institute’s ability to develop and test novel immunotherapeutic approaches. In addition to his...

Book Your Facebook Live Panel Discussion Now

Duke Cancer Institute’s Office of Communications is now hosting Facebook live panel discussions on a monthly basis. These discussions, known as #LunchAndLearn, a Recipe for Knowledge, usually take place at the Duke Cancer Center Patient Resource Room at noon on weekdays. Broadcasts are 15 minutes...

Diversity Training Pilot For Research Teams Launched

Low participation in cancer research and clinical trials is an ongoing national problem that contributes to cancer health disparities. Nationally, only about two to five percent of minorities participate in clinical trials. One primary reason most patients don’t participate in clinical trials,...

Miltier Named AD For Breast And GYN Oncology

Tonya Miltier, MBA, formerly performance services team lead, Duke Health, has been named administrative director for Duke Cancer Institute’s Breast and GYN disease groups. “We are delighted Tonya has accepted the role of administrative director for our women’s cancers,” said Laura Sample, MHA,...

Pages